KR910700048A - 오메프라졸의 항균제로서의 용도 - Google Patents

오메프라졸의 항균제로서의 용도

Info

Publication number
KR910700048A
KR910700048A KR1019900702221A KR900702221A KR910700048A KR 910700048 A KR910700048 A KR 910700048A KR 1019900702221 A KR1019900702221 A KR 1019900702221A KR 900702221 A KR900702221 A KR 900702221A KR 910700048 A KR910700048 A KR 910700048A
Authority
KR
South Korea
Prior art keywords
methoxy
campylobacter
sulfinyl
benzimidazole
pyridinyl
Prior art date
Application number
KR1019900702221A
Other languages
English (en)
Other versions
KR0140236B1 (ko
Inventor
마사끼 도모이
요시후미 이께다
요시꼬 요꼬다
Original Assignee
안데르스 베딘
악티에볼라게트 헤슬레
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=12300238&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR910700048(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 안데르스 베딘, 악티에볼라게트 헤슬레 filed Critical 안데르스 베딘
Publication of KR910700048A publication Critical patent/KR910700048A/ko
Application granted granted Critical
Publication of KR0140236B1 publication Critical patent/KR0140236B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

내용 없음.

Description

오메프라졸의 항균제로서의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 캠필로박터(Campylobacter) 박테리아 감염증 치료용 의약품의 제조를 위한 5-메톡시-2-〔〔(4-메톡시-3,5-디메틸-2-피리디닐)메틸〕술피닐〕-1H-벤즈이미다졸 또는 그의 제약상 허용되는 염의 용도.
  2. 캠필로박터 감염증 환자에게 5-메톡시-2-〔〔(4-메톡시-3,5-디메틸-2-피리디닐)메틸〕술피닐〕-1H-벤즈이미다졸 또는 그의 제약상 허용되는 염을 캠필로박터 감염증 치료에 충분한 양으로 투여하는 것으로 이루어진 캠필로박터 감염증 치료 방법.
  3. 활성 성분이 5-메톡시-2-〔〔(4-메톡시-3,5-디메틸-2-피리디닐)메틸〕술피닐〕-1H-벤즈이미다졸 또는 그의 제약상 허용되는 염인 캠필로박터 감염증 치료용 약제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900702221A 1989-02-09 1990-02-02 오메프라졸의 항균제로서의 용도 KR0140236B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP1/30311 1989-02-09
JP1030311A JP2694361B2 (ja) 1989-02-09 1989-02-09 抗菌剤
PCT/SE1990/000070 WO1990009175A1 (en) 1989-02-09 1990-02-02 Use of omeprazole as an antimicrobial agent

Publications (2)

Publication Number Publication Date
KR910700048A true KR910700048A (ko) 1991-03-13
KR0140236B1 KR0140236B1 (ko) 1998-06-01

Family

ID=12300238

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900702221A KR0140236B1 (ko) 1989-02-09 1990-02-02 오메프라졸의 항균제로서의 용도

Country Status (19)

Country Link
US (1) US5093342A (ko)
EP (1) EP0414847B1 (ko)
JP (1) JP2694361B2 (ko)
KR (1) KR0140236B1 (ko)
AT (1) ATE94063T1 (ko)
AU (1) AU626641B2 (ko)
CA (1) CA2025668C (ko)
CY (1) CY1909A (ko)
DE (1) DE69003207T2 (ko)
DK (1) DK0414847T3 (ko)
ES (1) ES2058892T3 (ko)
HK (1) HK52196A (ko)
HU (1) HU205253B (ko)
IE (1) IE65814B1 (ko)
IL (1) IL93263A0 (ko)
LV (1) LV10577B (ko)
MY (1) MY111737A (ko)
PH (1) PH26787A (ko)
WO (1) WO1990009175A1 (ko)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2066120T3 (es) * 1989-02-10 1995-03-01 Takeda Chemical Industries Ltd Uso de derivados de bencimidazol como agentes antibacterianos.
GB9018603D0 (en) * 1990-08-24 1990-10-10 Smith Kline French Lab Compositions
WO1992004898A1 (de) * 1990-09-14 1992-04-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Verwendung von pyridylmethylsulfinyl-1h-benzimidazol derivaten zur behandlung durch helicobacter verursachten erkrankungen
IL105155A (en) * 1992-04-24 1999-05-09 Astra Ab Synergistic combination of an inhibitor of gastric acid secretion with an acid-breaking antibiotic
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
AU5699594A (en) * 1992-12-10 1994-07-04 Byk Gulden Lomberg Chemische Fabrik Gmbh Use of alkylthiopyridines for controlling helicobacter bacteria
US6902738B2 (en) * 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
AU4596796A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with bismuth and antibacterials
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
US5708017A (en) * 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
SI9700186B (sl) 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
ATE260090T1 (de) * 1997-12-08 2004-03-15 Altana Pharma Ag Neue suppositoriumsform mit säureempfindliche wirkstoffe
US6861448B2 (en) * 1998-01-14 2005-03-01 Virtual Drug Development, Inc. NAD synthetase inhibitors and uses thereof
WO1999036422A1 (en) 1998-01-14 1999-07-22 The Uab Research Foundation Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme
US6733778B1 (en) * 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
EP1469839A2 (en) * 2002-01-25 2004-10-27 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
JP2006518751A (ja) * 2003-02-20 2006-08-17 サンタラス インコーポレイティッド 胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
TWI337877B (en) * 2003-07-18 2011-03-01 Santarus Inc Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
KR101348643B1 (ko) 2006-03-10 2014-01-08 링크 제노믹스 가부시키가이샤 항 헬리코박터피로리 작용을 가지는 신규 피리딘 유도체
EP2068841B1 (en) 2006-10-05 2018-09-26 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2486910A3 (en) 2006-10-27 2012-08-22 The Curators Of The University Of Missouri Multi-chambered apparatus comprising a dispenser head
PL2103608T3 (pl) 2006-12-18 2013-02-28 Link Genomics Inc Środek do eradykacji Helicobacter pylori mający działanie hamujące na sekrecję kwasu żołądkowego
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
JP5564517B2 (ja) 2009-02-20 2014-07-30 ティーオー − ビービービー ホールディング ベスローテン フェンノートシャップ グルタチオンをベースとする薬物送達システム
WO2010116740A1 (ja) 2009-04-09 2010-10-14 アリジェン製薬株式会社 ピリジンチオ誘導体及びそれを含有する抗ヘリコバクター・ピロリ作用を有する医薬組成物
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US8992897B2 (en) 2010-01-06 2015-03-31 Elc Management Llc Skin lightening compositions
US8722026B2 (en) * 2010-01-06 2014-05-13 Elc Management, Llc Skin lightening compositions
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
KR101628474B1 (ko) * 2014-08-27 2016-06-08 경북대학교 산학협력단 오메프라졸을 유효성분으로 포함하는 피부 미백용 화장료 조성물
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
HU886738D0 (en) * 1987-10-30 1990-02-28 Haessle Ab Process for the preparation of pharmaceutical compositions against osteoporosis containing 2-pyridinyl-methyl-(sulfinyl or thio)-benzimidazoles

Also Published As

Publication number Publication date
EP0414847B1 (en) 1993-09-08
US5093342A (en) 1992-03-03
MY111737A (en) 2000-12-30
AU626641B2 (en) 1992-08-06
KR0140236B1 (ko) 1998-06-01
CY1909A (en) 1990-02-02
AU5038190A (en) 1990-09-05
LV10577A (lv) 1995-04-20
DE69003207D1 (de) 1993-10-14
EP0414847A1 (en) 1991-03-06
HK52196A (en) 1996-03-29
PH26787A (en) 1992-10-13
IE65814B1 (en) 1995-11-15
ATE94063T1 (de) 1993-09-15
WO1990009175A1 (en) 1990-08-23
CA2025668A1 (en) 1990-08-10
IL93263A0 (en) 1990-11-29
ES2058892T3 (es) 1994-11-01
IE900418L (en) 1990-08-09
HU901539D0 (en) 1991-02-28
LV10577B (en) 1995-10-20
HUT54890A (en) 1991-04-29
CA2025668C (en) 1998-09-15
DE69003207T2 (de) 1994-02-03
JPH02209809A (ja) 1990-08-21
HU205253B (en) 1992-04-28
DK0414847T3 (da) 1993-12-13
JP2694361B2 (ja) 1997-12-24

Similar Documents

Publication Publication Date Title
KR910700048A (ko) 오메프라졸의 항균제로서의 용도
BRPI0011674B8 (pt) cristal de (r)-2-[[[3-metil-4-(2,2,2-trifluoroetóxi)-2-piridinil]metil] sulfinil]-1h-benzimidazol, composição farmacêutica, e, uso do referido cristal
AR010361A1 (es) "S-OMEPRAZOL [ENANTIoMERO S DE 5-METOXI-2-[[(4--METOXI-3,5-DIMETIL-2-PIRIDINIL)-METIL]SULFINIL]-1H-BENCIMIDAZOL], EN UNA FORMA NEUTRA NO SALINA, PROCESO PARA SU PREPARACION, COMPOSICION FARMACEUTICA, Y SU USO PARA LA MANUFACTURA DE MEDICAMENTOS"
DE69931159D1 (de) Antimikrobielle zusammensetzungen enthaltend taurolidin, zitronensäure und natriumzitrat
DE69012138D1 (de) Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
FI913036A0 (fi) Terapeutiskt aktiv substituerad benzimidazol och foerfarande foer dess framstaellning.
ATE282406T1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
BR0209103A (pt) Omeprazol forma c, processo para preparação e uso do mesmo e formulação farmacêutica
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
DE69125940D1 (de) Pharmazeutische zusammensetzungen die 5-difluormethoxy-2-[3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1h-benzimidazol und ein anti-heliobactermittel enthalten zur behandlung von magen-darm krankheiten
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
NO912942D0 (no) Vaksine for preventiv behandling av infeksjon av leverikte hos droevtyggere.
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
KR900017599A (ko) 종양 치료용 약학 조성물
KR890001555A (ko) 요산 배설용 조성물
KR930007452A (ko) 벤조디아제핀-금단 환자의 불안증 치료방법

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20080117

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee